Patents by Inventor Svetomir N. Markovic

Svetomir N. Markovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170182187
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: March 16, 2017
    Publication date: June 29, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170182174
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170182185
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170182180
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: March 16, 2017
    Publication date: June 29, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170182184
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170128408
    Abstract: Described are stable nanoparticle complexes comprising paclitaxel, albumin and alemtuzumab. The nanoparticle complexes are suitable for the treatment of cancer.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170128585
    Abstract: Described are nanoparticle complexes comprising paclitaxel, albumin and antibody. The nanoparticle complexes are suitable for the treatment of cancer.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170128583
    Abstract: Described are nanoparticle complexes comprising paclitaxel, albumin and trastuzumab. The nanoparticle complexes are suitable for the treatment of cancer.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170128588
    Abstract: Described are stable nanoparticle complexes comprising paclitaxel, albumin and ofatumumab. The nanoparticle complexes are suitable for the treatment of cancer.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170128586
    Abstract: Described are nanoparticle complexes comprising paclitaxel, albumin and panitumumab. The nanoparticle complexes are suitable for the treatment of cancer.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170128587
    Abstract: Described are stable nanoparticle complexes comprising paclitaxel, albumin and rituximab. The nanoparticle complexes are suitable for the treatment of cancer.
    Type: Application
    Filed: January 24, 2017
    Publication date: May 11, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170128584
    Abstract: Described are nanoparticle complexes comprising paclitaxel, albumin and anti-EGFR antibodies. The nanoparticle complexes are suitable for the treatment of cancer, in particular cancer that expresses EGFR.
    Type: Application
    Filed: January 23, 2017
    Publication date: May 11, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170106087
    Abstract: This document provides methods and materials related to treating cancer (e.g., skin cancer). For example, methods and materials relating to the use of a composition containing albumin-containing nanoparticle/antibody complexes (e.g., Abraxane®/anti-VEGF polypeptide antibody complexes) to treat cancer (e.g., skin cancer) are provided.
    Type: Application
    Filed: August 1, 2016
    Publication date: April 20, 2017
    Inventors: Svetomir N. MARKOVIC, Wendy K. NEVALA
  • Publication number: 20170100492
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: October 21, 2016
    Publication date: April 13, 2017
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. MARKOVIC, Wendy K. NEVALA
  • Publication number: 20170095574
    Abstract: Described herein are methods, formulations and kits for treating a patient with cancer with anti-VEGF antibodies and albumin-bound chemotherapeutic/anti-VEGF antibody nanoparticle complexes.
    Type: Application
    Filed: April 6, 2016
    Publication date: April 6, 2017
    Inventors: Gerald F. SWISS, Svetomir N. MARKOVIC, Wendy K. NEVALA
  • Publication number: 20170071897
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Svetomir N. MARKOVIC, Wendy K. NEVALA
  • Patent number: 9566350
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Grant
    Filed: March 8, 2016
    Date of Patent: February 14, 2017
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Patent number: 9555128
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: January 31, 2017
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Svetomir N. Markovic, Wendy K. Nevala
  • Publication number: 20170021032
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: October 5, 2016
    Publication date: January 26, 2017
    Inventors: Svetomir N. MARKOVIC, Wendy K. NEVALA
  • Publication number: 20170021034
    Abstract: Described herein are compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic. Also described are lyophilized compositions of antibodies and carrier proteins and methods of making and using the same, in particular, as a cancer therapeutic.
    Type: Application
    Filed: October 5, 2016
    Publication date: January 26, 2017
    Inventors: Svetomir N. MARKOVIC, Wendy K. NEVALA